Process View
The multiplication or reproduction of glomerular mesangial cells, resulting in the expansion of the population.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "glomerular mesangial cell proliferation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1.000 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.999 | ||
| NRP1 | neuropilin 1 | 0.998 | ||
| VEGFA | vascular endothelial growth factor A | 0.997 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.987 | Mouse | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.939 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.921 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.863 | Human | |
| PLCG1 | phospholipase C, gamma 1 | 0.754 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.686 | ||
| PGF | placental growth factor | 0.634 | Human | |
| FSTL1 | follistatin-like 1 | 0.606 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.605 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.544 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.445 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.395 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.302 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.266 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.266 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.258 | ||
| NOG | noggin | 0.236 | ||
| PDGFC | platelet derived growth factor C | 0.214 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.173 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.156 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.151 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.127 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.125 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.107 | ||
| IER2 | immediate early response 2 | 0.095 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.089 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.087 | ||
| EGR3 | early growth response 3 | 0.085 | ||
| EGR2 | early growth response 2 | 0.080 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.078 | ||
| BMP4 | bone morphogenetic protein 4 | 0.071 | ||
| STC1 | stanniocalcin 1 | 0.067 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.064 | ||
| SLA | Src-like-adaptor | 0.062 | ||
| BMP2 | bone morphogenetic protein 2 | 0.055 | Human | |
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.050 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.049 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.043 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.041 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.041 | ||
| MDFI | MyoD family inhibitor | 0.038 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.037 | ||
| PTEN | phosphatase and tensin homolog | 0.035 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.032 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.032 | ||
| JUNB | jun B proto-oncogene | 0.030 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.029 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.024 | ||
| FST | follistatin | 0.023 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.021 | ||
| LDLR | low density lipoprotein receptor | 0.021 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.020 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.020 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.020 | ||
| NRP2 | neuropilin 2 | 0.020 | ||
| TAOK1 | TAO kinase 1 | 0.020 | ||
| TBX2 | T-box 2 | 0.019 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.019 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.019 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.018 | ||
| ZNF205 | zinc finger protein 205 | 0.018 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.018 | ||
| FOXF1 | forkhead box F1 | 0.018 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.018 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.018 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.018 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.017 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.017 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.017 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.017 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.016 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.016 | ||
| NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) | 0.016 | ||
| INHBB | inhibin, beta B | 0.016 | ||
| DVL1 | dishevelled, dsh homolog 1 (Drosophila) | 0.016 | ||
| BMP8B | bone morphogenetic protein 8b | 0.016 | Human | |
| BMP6 | bone morphogenetic protein 6 | 0.016 | Human | |
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.016 | ||
| FYB | FYN binding protein | 0.016 | ||
| SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 | 0.015 | ||
| G0S2 | G0/G1switch 2 | 0.015 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.015 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.015 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.015 | ||
| GAS1 | growth arrest-specific 1 | 0.014 | ||
| STC2 | stanniocalcin 2 | 0.014 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.014 | ||
| NCK2 | NCK adaptor protein 2 | 0.014 | ||
| CD248 | CD248 molecule, endosialin | 0.013 | ||
| WISP2 | WNT1 inducible signaling pathway protein 2 | 0.013 | ||
| ANGPT2 | angiopoietin 2 | 0.013 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.013 | ||
| TRIB1 | tribbles homolog 1 (Drosophila) | 0.013 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.013 | ||
| NPM3 | nucleophosmin/nucleoplasmin 3 | 0.013 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.013 | ||
| TWIST1 | twist homolog 1 (Drosophila) | 0.013 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.013 | ||
| HAND1 | heart and neural crest derivatives expressed 1 | 0.012 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.012 | ||
| EFNB3 | ephrin-B3 | 0.012 | ||
| JAG1 | jagged 1 | 0.012 | ||
| FOXF2 | forkhead box F2 | 0.012 | ||
| BMP3 | bone morphogenetic protein 3 | 0.012 | Human | |
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.011 | ||
| JUND | jun D proto-oncogene | 0.011 | ||
| MMP19 | matrix metallopeptidase 19 | 0.011 | ||
| ACAN | aggrecan | 0.011 | ||
| SOD3 | superoxide dismutase 3, extracellular | 0.011 | ||
| PITX2 | paired-like homeodomain 2 | 0.011 | ||
| VLDLR | very low density lipoprotein receptor | 0.011 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.011 | ||
| CER1 | cerberus 1, cysteine knot superfamily, homolog (Xenopus laevis) | 0.011 | ||
| EDN1 | endothelin 1 | 0.011 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.011 | ||
| THBS1 | thrombospondin 1 | 0.011 | ||
| COL13A1 | collagen, type XIII, alpha 1 | 0.010 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.010 | ||
| FZD2 | frizzled homolog 2 (Drosophila) | 0.010 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.010 | ||
| NDRG1 | N-myc downstream regulated 1 | 0.010 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.010 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.010 |